A Fully Validated LC‑MS/MS Method for Quantifying Bevacizumab in Plasma Samples from Patients with NSCLC and Its Implications in Therapeutic Drug Monitoring.
ONCOLOGY LETTERS（2024）
Key words
bevacizumab,monoclonal antibody,nano-surface and molecular-orientation limited proteolysis,ultra-performance liquid chromatography tandem mass spectrometry,therapeutic drug monitoring
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined